Home > Healthcare > Medical Devices > Therapeutic Devices > Europe and MENA Wound Care Market

Europe and MENA Wound Care Market Trends

Report ID: GMI11893
Published Date: Oct 2024
Report Format: PDF

Download Free Sample

Europe and MENA Wound Care Market Trends

The prevalence of chronic diseases such as diabetes, obesity, and vascular disorders across Europe is leading to an increase in chronic wounds, including diabetic foot ulcers and pressure ulcers. This trend is driving up the demand for advanced wound care solutions, encompassing dressings, negative pressure wound therapy (NPWT), and skin substitutes.
Advancements in wound care products are broadening treatment possibilities. These innovations include bioactive dressings, antimicrobial dressings, and progression factor-infused therapies. Additionally, the adoption of artificial intelligence (AI) and digital wound management tools for monitoring healing progress is gaining traction in Europe.
Governments in the Middle East and North Africa (MENA) region are investing in healthcare infrastructure improvements, with an emphasis on enhancing access to advanced treatments for chronic conditions. This investment has resulted in increased availability and utilization of advanced wound care products in hospitals and clinics throughout the region.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size for Europe and MENA wound care was valued at approximately USD 7.5 billion in 2023 and is expected to reach around USD 12.7 billion by 2032, driven by a CAGR of 6% from 2024 to 2032.

Advanced wound dressings accounted for the largest revenue of USD 2.4 billion in 2023, driven by their ability to significantly accelerate the healing process.

The Europe wound care market generated USD 6.9 billion in 2023, driven by the high prevalence of chronic diseases such as diabetes and cardiovascular conditions.

Some of the major players include Advancis Medical, B. Braun Melsungen, Baxter International, Coloplast, Convatec Group, Essity, Integra LifeSciences Holdings Corporation, Johnson & Johnson, and Medline Industries, driven by their continuous innovation and technological advancements in wound care products.